| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/01/1989 | WO1989004670A1 Process for producing antibodies |
| 06/01/1989 | WO1989004669A1 Nanbv diagnostics and vaccines |
| 06/01/1989 | WO1989003396A3 Antibodies to natural killer cell and non-specific cytotoxic cell receptor |
| 05/31/1989 | EP0318296A2 Interleukin-1 receptors |
| 05/31/1989 | EP0318216A1 NANBV diagnostics and vaccines |
| 05/31/1989 | EP0318081A1 Stabilization of antibodies |
| 05/31/1989 | EP0317957A2 Drug-monoclonal antibody conjugates |
| 05/31/1989 | EP0317641A1 Fused protein containing lymphotoxin |
| 05/31/1989 | EP0317595A1 Hiv polypeptide, its preparation and use in detection of hiv antibodies |
| 05/31/1989 | EP0317569A1 2-component immunoadjuvant |
| 05/31/1989 | EP0162914B1 Novel immunoassays and kits for use therein |
| 05/30/1989 | US4835259 Malaria antigens |
| 05/30/1989 | US4835258 Conjugation of aromatic amines or nitro-containing compounds with proteins or polypeptides by photoirradiation of the azide derivatives with ultraviolet light in order to produce antibodies against the haptens |
| 05/30/1989 | US4834975 Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production |
| 05/30/1989 | US4834974 Immunologically active whey fraction and recovery process |
| 05/30/1989 | US4834973 Immunological methods for treating mammals |
| 05/30/1989 | CA1254846A1 Monoclonal antibodies against melanocytes and melanomas |
| 05/24/1989 | EP0317114A1 Automatic chromatography apparatus |
| 05/24/1989 | EP0317001A1 A new universally applicable detection system based 0n ultra small colloidal metal particles |
| 05/24/1989 | EP0316882A2 Monoclonal antibody recognizing alpha 2-- 3 bonds |
| 05/24/1989 | EP0316818A2 Monoclonal antibodies capable of recognizing N-acetylneuraminic acid in beta-arrangement |
| 05/24/1989 | EP0316776A2 Monoclonal antibodies to anthracyclines |
| 05/24/1989 | EP0316695A1 Recombinant HIV-2 polypeptides |
| 05/24/1989 | EP0316658A1 Infectious bovine rhinotracheitis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same |
| 05/24/1989 | EP0316425A1 A SV40 EXPRESSION VECTOR CONTAINING HBxAg AS AN EXPRESSION MARKER |
| 05/24/1989 | EP0316354A1 Genes encoding antigens of m. leprae |
| 05/24/1989 | CN1033074A Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes |
| 05/24/1989 | CN1033072A Recombinant dna-derived bordetella toxin subvnit analogs |
| 05/24/1989 | CN1033008A Vaccine against e. coli septicaemia in poultry |
| 05/23/1989 | US4833085 Monoclonal antibody specific for human colon fibroblast-derived t-PA |
| 05/23/1989 | US4833074 Purified human granylocyte L1 proteins methods for their preparation, monospecific antibodies and test kits |
| 05/23/1989 | US4833072 Polypeptides, aids |
| 05/23/1989 | US4833071 Peptide composition as anitgen for detection of antibodies to HTLV-I, as a vaccine for ATL and methods therefor |
| 05/23/1989 | US4832940 Method of locating or imaging activated T-lymphocytes with a targeting polypeptide |
| 05/18/1989 | WO1989004370A1 Human monoclonal anti-hiv-i-antibodies |
| 05/18/1989 | WO1989004327A1 Human monoclonal antibody against aspergilli |
| 05/18/1989 | WO1989004322A1 Purification by affinity binding to liposomes |
| 05/18/1989 | WO1989004181A1 Immunization |
| 05/18/1989 | WO1989004175A1 Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes |
| 05/18/1989 | WO1989004174A1 Anti-c3bi receptor (cr3) antibodies and therapeutic composition |
| 05/18/1989 | WO1989003846A3 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
| 05/18/1989 | WO1989002277A3 Prophylaxis and therapy of acquired immunodeficiency syndrome |
| 05/17/1989 | EP0316306A2 Monoclonal antibodies special for HB A1c |
| 05/17/1989 | EP0316212A1 Use of nitrophenyls or anti-nitrophenyl antibodies for modification of the interaction between host-sensitive cells and a pathogenic agent |
| 05/17/1989 | EP0316170A2 Method for the identification of antigens expressed in vivo, diagnostic assays therefor and vaccines containing them |
| 05/16/1989 | US4831121 Polydisperse native pseudomonas flagellar (H) antigens (FAg) and methods of producing them |
| 05/16/1989 | US4831020 Ingredient effective for activating immunity obtained from Chlorella minutissima |
| 05/16/1989 | US4830962 Expression vectors encoding for a dt-a fragment which use dna control sequences not native to the coding sequences but compatible to the host |
| 05/16/1989 | US4830857 Cosmetic and pharmaceutical compositions containing niosomes and a water-soluble polyamide, and a process for preparing these compositions |
| 05/16/1989 | US4830852 Covalent-modification and having a coupling spacer containing a thioether; vaccines; chemical stability; infant protection |
| 05/16/1989 | US4830847 Radioactive proteins |
| 05/16/1989 | CA1254161A1 Herpes virus specific immunological materials and methods |
| 05/16/1989 | CA1254139A1 Pharmaceutical composition comprising a combination of at least one immunotoxin and at least one mannose-containing polymer |
| 05/16/1989 | CA1254133A1 Process and reagent for the determination of an immunologically-bindable substance |
| 05/16/1989 | CA1254132A1 Method of concentrating and detecting bio-molecules and cells and a means therefor |
| 05/10/1989 | EP0315459A2 HIV incomplete particles and a method for production thereof |
| 05/10/1989 | EP0315456A2 Polysaccharide-modified immunoglobulins having reduced immunogenic potential or improved pharmacokinetics |
| 05/10/1989 | EP0315242A2 Process for purifying recombinant hepatitis antigens |
| 05/10/1989 | EP0315188A2 Methods and materials for the preparation of metal labelled antibody solutions |
| 05/10/1989 | EP0315153A2 Vaccine adjuvant |
| 05/10/1989 | EP0315110A2 Use of the tumor necrosis factor as adjuvant of the immune response |
| 05/10/1989 | EP0315085A2 Recombinant histidine-rich protein from Plasmodium falciparum, its synthesis and use |
| 05/10/1989 | EP0315062A2 Production of chimeric antibodies by homologous recombination |
| 05/10/1989 | EP0314863A2 Use of ICAM-1 or its functional derivatives for the treatment of non-specific inflammation |
| 05/10/1989 | CN1032816A Monoclonal antibodies against human interleukin-4 and hybridomas producing same |
| 05/09/1989 | US4829101 Polymer particles and latices thereof for the immobilization of biologically active substances |
| 05/09/1989 | US4828985 Antibodies against the complex of a small molecule and its binding protein, their preparation and their use in diagnostic methods |
| 05/09/1989 | US4828981 Competitive, homogeneous or heterogeneous |
| 05/09/1989 | US4827945 Magnetic resonance imaging |
| 05/09/1989 | CA1253816A1 Monoclonal antibodies against alveolar surfactant protein |
| 05/05/1989 | WO1989003996A1 Human gamma, delta t cell antigen receptor polypeptides and nucleic acids |
| 05/05/1989 | WO1989003884A1 Interleukin-7 |
| 05/05/1989 | WO1989003879A1 Fowlpox virus promoters |
| 05/05/1989 | WO1989003846A2 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
| 05/05/1989 | WO1989003845A1 Ps2 protein derivative |
| 05/05/1989 | WO1989003844A1 Hiv peptides, artificial hiv antigens and immunoassay kits |
| 05/05/1989 | WO1989003836A1 Factors associated with essential hypertension |
| 05/05/1989 | WO1989003690A1 Application of dinitro-trinitrophenyl and its derivatives or of anti-nitrophenyl antibodies to the modification of the interaction between the target cellules of a host and a pathogenic agent |
| 05/03/1989 | EP0314569A1 Recombinant fowlpox virus, expression vectors for heterologous proteins, and vaccines for fowl derived from this virus |
| 05/03/1989 | EP0314534A1 Expression vector for proteins from the HIV-2 virus, one of the agents that cause AIDS |
| 05/03/1989 | EP0314415A2 Interleukin-7 |
| 05/03/1989 | EP0314402A2 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
| 05/03/1989 | EP0314240A2 Process for purifying recombinant hepatitis antigens |
| 05/03/1989 | EP0314224A1 Vaccine against E.coli septicaemia in poultry |
| 05/03/1989 | EP0314161A1 Human immunoglobulines produced by recombinant DNA techniques |
| 05/03/1989 | EP0313997A2 Medicine, therein contained phosphor containing 2-isoxazolidines and isoxazoles, as well as process for preparing those heterocyclic compounds |
| 05/03/1989 | EP0313874A2 Disulfur analogs of LL-E33288 antitumor agents |
| 05/03/1989 | EP0313873A1 Targeted forms of methyltrithio antitumor agents |
| 05/03/1989 | EP0313641A1 Activation antigen |
| 05/03/1989 | DE3836006A1 Monophosphoryllipid-a-derivate und verfahren zu deren herstellung Monophosphoryl lipid A derivatives and methods for their preparation |
| 05/03/1989 | DE3735777A1 Carrier-bound mono- or polyclonal antibody |
| 05/02/1989 | US4826957 Immunogenic recombinant yeast expression product and method for purifying it |
| 05/02/1989 | US4826687 Influenza vaccine |
| 05/02/1989 | CA1253422A1 Visualization method for the direct or indirect detection of the reaction between a specific binding agent and the corresponding acceptor substance in blot overlay assays |
| 04/26/1989 | EP0313156A1 SnRNP-A antigen and fragments thereof |
| 04/26/1989 | EP0313008A2 Magnetic membrane capsules and their use |
| 04/26/1989 | EP0312996A2 Anti-human bcdf monoclonal antibody |
| 04/26/1989 | EP0312907A2 Immuno-reactive support material |
| 04/26/1989 | EP0312839A2 Method for the preparation of an inducer of non-specific immunity |
| 04/26/1989 | EP0312645A1 Antigenic peptides from complement factor C3a, use of peptides, cell lines, antibodies against the peptides and utilisation of the antibodies |